Document is current
Any future updates will be listed below
-
Authors
Yasuma, Reo
Cicatiello, Valeria
Mizutani, Takeshi
Tudisco, Laura
Kim, Younghee
Tarallo, Valeria
Bogdanovich, Sasha
Hirano, Yoshio
Kerur, Nagaraj
Li, Shengjian
Yasuma, Tetsuhiro
Fowler, Benjamin J
Wright, Charles B
Apicella, Ivana
Greco, Adelaide
Brunetti, Arturo http://orcid.org/0000-0001-7057-3494
Ambati, Balamurali K
Helmers, Sevim Barbasso
Lundberg, Ingrid E
Viklicky, Ondrej
Leusen, Jeanette HW
Verbeek, J Sjef
Gelfand, Bradley D
Bastos-Carvalho, Ana
De Falco, Sandro
Ambati, Jayakrishna
- License Information
-
More Information
Article History
Received: 29 August 2015
Revised: 25 November 2015
Accepted: 25 November 2015
First Online: 28 January 2016
Competing interests
: JA is a co-founder of iVeena Holdings, iVeena Pharmaceuticals, iVeena Delivery Systems and Inflammasome Therapeutics, and has received honoraria from Allergan and research funding from Olix Pharmaceuticals unrelated to this work. JA and SDeF are named as inventors on patent applications filed by the University of Kentucky relating to the technology described in this work.
